This cell line is a modified version of iPS DF19-9-7T, genetically engineered by ZNFs to insert a DOX-inducible ETV2 construct into AAVS1 locus.  Overexpression of ETV2 at different stages of differentiation can be used to study endothelial and hematopoietic specification from hPSCs. In addition, this cell line can be used to generate endothelial cells from hPSCs by treatment with doxycycline.

  • Cell Line Alias pZD14-iPSC1C129, WAi001-B-1, WISCi017-A-1
  • Unit of Measure (UOM) vial
  • Cell Type Modified Human iPS
  • Sex Male
  • Genetic Modification Keyword Reporter; Endothelial
  • Disease None reported
  • Genetic Alteration Mutation ETV2
  • hPSCReg ID WAi001-B-1
  • Provider University of Wisconsin - Dr. Igor Slukvin
  • Collections
Please log-in to add to your cart.

Lot Number Culture Platform Lot Description Banked By Passage Number Protocol Product Information & Testing
WB67568 TeSR-E8/Matrigel WiCell 7 WiCell Feeder Independent Pluripotent Stem Cell Protocol PDF

WiCell